 | • レポートコード：MRC-IM30700 • 出版社/出版日：IMARC / 2023年2月 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2022年36億ドルであった世界のMRSA治療薬市場規模が2028年には45億ドルに達し、予測期間中（2023年-2028年）、年平均3.6％成長すると予測しています。当調査資料では、MRSA治療薬の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、MRSAタイプ別（病院取得（HA-MRSA）、市中取得（CA-MRSA））分析、薬剤クラス別（リポペプチド、オキサゾリジノン、セファロスポリン、テトラサイクリン、その他）分析、疾患別（皮膚感染症、骨＆関節感染症、菌血症、動物感染症）分析、投与経路別（経口投与、非経口投与）分析、地域別（北米、アジア、欧州、中南米、中東/アフリカ）分析、要因・制約・機会、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。なお、当市場の主要企業には、AbbVie Inc.、Basilea Pharmaceutica Ltd、Crystal Genomics Inc.、Cumberland Pharmaceuticals Inc.、Melinta Therapeutics Inc、Paratek Pharmaceuticals、Inc.、Pfizer Incなどが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界のMRSA治療薬市場規模：MRSAタイプ別 - 病院取得（HA-MRSA）の市場規模 - 市中取得（CA-MRSA）の市場規模 ・世界のMRSA治療薬市場規模：薬剤クラス別 - リポペプチドの市場規模 - オキサゾリジノンの市場規模 - セファロスポリンの市場規模 - テトラサイクリンの市場規模 - その他薬剤クラスの市場規模 ・世界のMRSA治療薬市場規模：疾患別 - 皮膚感染症の市場規模 - 骨＆関節感染症の市場規模 - 菌血症の市場規模 - 動物感染症の市場規模 ・世界のMRSA治療薬市場規模：投与経路別 - 経口投与の市場規模 - 非経口投与の市場規模 ・世界のMRSA治療薬市場規模：地域別 - 北米のMRSA治療薬市場規模 - アジアのMRSA治療薬市場規模 - 欧州のMRSA治療薬市場規模 - 中南米のMRSA治療薬市場規模 - 中東/アフリカのMRSA治療薬市場規模 ・要因・制約・機会 ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global MRSA drugs market size reached US$ 3.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2028, exhibiting a growth rate (CAGR) of 3.6% during 2023-2028. The rising prevalence of antibiotic resistant strains development, continual exposure to multidrug-resistant organisms in healthcare facilities due to prolonged hospital admission and the growing number of clinical trials represent some of the key factors driving the market.
Methicillin-resistant staphylococcus aureus (MRSA) is an infection caused by antibiotic-resistant strains of staphylococcus aureus that generally occurs in patients who undergo surgical procedures, receive intravenous tubing, or come in contact with each other skin-to-skin. The MRSA drugs are used as antimicrobial agents against methicillin-resistant staphylococcus aureus infection in order to kill or restrain it. They inhibit the actions of pathogens while enhancing the patient’s cellular synthesis and immunity. The most common MRSA drugs consist of trimethoprim-sulfamethoxazole, clindamycin, minocycline, linezolid, or doxycycline. These drugs are generally used as oral medication, usually on a course of seven to ten days. MRSA infections can arise from hospitals or from community, hence the treatment for MRSA can sometimes involve the administration of oral medications and intravenous (IV) medications, depending on the severity. There are a wide variety of MRSA drugs available that can be used for the treatment of different types of infections, including skin infections, bone infections, bacteremia, and even zoonotic infections in animals.
MRSA Drugs Market Trends:
The rising prevalence of antibiotic resistant strains development among the masses is a significant factor driving the growth of the market. This can be attributed to the increase in the number of cases of hospital-acquired infections (HAIs) on the global level. Also, the continual exposure to multidrug-resistant organisms in healthcare facilities due to prolonged hospital admission is resulting in the development of secondary nosocomial infections, thereby propelling the market. In addition to this, the growing geriatric population that is more susceptible to developing MRSA infections is providing an impetus to the market. Moreover, the augmenting awareness regarding different forms of bacterial infection is leading to a higher uptake of MRSA drugs. In line with this, numerous product innovations, growing number of clinical trials and the introduction of novel drug variants are creating lucrative growth opportunities in the market. However, the high costs involved in developing novel MRSA drug variants is acting as major growth restraining-factor for the market. On the contrary, continual technological developments in various diagnostic tools, along with the increasing number of clinical trial programs for the screening of antibiotic resistant strains of bacteria, are creating a positive market outlook. The market is further impelled by extensive research and development (R&D) activities conducted by the key players. Some of the other factors contributing to the market include the emergence of generic drugs against presently available products, easy availability of antibiotics across online and offline organized platforms, rapid urbanization, and increasing medical expenditure.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global MRSA drugs market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on MRSA type, drug class, disease indication, route of administration, and distribution channel.
MRSA Type Insights
Hospital-Acquired (HA-MRSA)
Community-Acquired (CA-MRSA)
The report has provided a detailed breakup and analysis of the MRSA drugs market based on the MRSA type. This includes Hospital-Acquired (HA-MRSA) and Community-Acquired (CA-MRSA). According to the report, Hospital-Acquired (HA-MRSA) represented the largest segment.
Drug Class Insights
Lipopeptides
Oxazolidinones
Cephalosporin
Tetracycline
Folate Antagonist
Others
The report has provided a detailed breakup and analysis of the MRSA drugs market based on the drug class. This includes lipopeptides, oxazolidinones, cephalosporin, tetracycline, folate antagonist, and others. According to the report, lipopeptides represented the largest segment.
Disease Indication Insights
Skin Infections
Bone and Joint Infections
Bacteremia
Animal Infections
The report has provided a detailed breakup and analysis of the MRSA drugs market based on the disease indication. This includes skin infections, bone and joint infections, bacteremia, and animal infections. According to the report, skin Infections represented the largest segment.
Route of Administration Insights
Oral Administration
Parenteral Administration
The report has provided a detailed breakup and analysis of the MRSA drugs market based on the route of administration. This includes oral administration and parenteral administration. According to the report, parenteral administration represented the largest segment.
Distribution Channel Insights
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
A detailed breakup and analysis of the MRSA drugs market based on the distribution channel has also been provided in the report. This includes hospital pharmacies, retail pharmacies, and online pharmacies. According to the report, hospital pharmacies accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for MRSA drugs. Some of the factors driving the North America MRSA drugs market include the rising medical expenditure, the increasing number of clinical trial programs, extensive research and development (R&D) activities conducted by key players, etc.
Competitive Landscape
The report has also provided a comprehensive analysis of the competitive landscape in the global MRSA drugs market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AbbVie Inc., Basilea Pharmaceutica Ltd, Crystal Genomics Inc., Cumberland Pharmaceuticals Inc., Melinta Therapeutics Inc, Paratek Pharmaceuticals, Inc., Pfizer Inc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
How has the global MRSA drugs market performed so far and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global MRSA drugs market?
What are the key regional markets?
Which countries represent the most attractive MRSA drugs markets?
What is the breakup of the market based on the MRSA type?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the disease indication?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What is the competitive structure of the global MRSA drugs market?
Who are the key players/companies in the global MRSA drugs market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global MRSA Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by MRSA Type
6.1 Hospital-Acquired (HA-MRSA)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Community-Acquired (CA-MRSA)
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Class
7.1 Lipopeptides
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oxazolidinones
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cephalosporin
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Tetracycline
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Folate Antagonist
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Disease Indication
8.1 Skin Infections
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Bone and Joint Infections
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Bacteremia
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Animal Infections
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Route of Administration
9.1 Oral Administration
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Parenteral Administration
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Retail Pharmacies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Online Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 Drivers, Restraints, and Opportunities
12.1 Overview
12.2 Drivers
12.3 Restraints
12.4 Opportunities
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 AbbVie Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Basilea Pharmaceutica Ltd
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 Crystal Genomics Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Cumberland Pharmaceuticals Inc
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.5 Melinta Therapeutics Inc
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.6 Paratek Pharmaceuticals, Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Pfizer Inc
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Figure 1: Global: MRSA Drugs Market: Major Drivers and ChallengesFigure 2: Global: MRSA Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: MRSA Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: MRSA Drugs Market: Breakup by MRSA Type (in %), 2022
Figure 5: Global: MRSA Drugs Market: Breakup by Drug Class (in %), 2022
Figure 6: Global: MRSA Drugs Market: Breakup by Disease Indication (in %), 2022
Figure 7: Global: MRSA Drugs Market: Breakup by Route of Administration (in %), 2022
Figure 8: Global: MRSA Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 9: Global: MRSA Drugs Market: Breakup by Region (in %), 2022
Figure 10: Global: MRSA Drugs (Hospital-Acquired (HA-MRSA)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: MRSA Drugs (Hospital-Acquired (HA-MRSA)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: MRSA Drugs (Community-Acquired (CA-MRSA)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: MRSA Drugs (Community-Acquired (CA-MRSA)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: MRSA Drugs (Lipopeptides) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: MRSA Drugs (Lipopeptides) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: MRSA Drugs (Oxazolidinones) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: MRSA Drugs (Oxazolidinones) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: MRSA Drugs (Cephalosporin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: MRSA Drugs (Cephalosporin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: MRSA Drugs (Tetracycline) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: MRSA Drugs (Tetracycline) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: MRSA Drugs (Folate Antagonist) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: MRSA Drugs (Folate Antagonist) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: MRSA Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: MRSA Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: MRSA Drugs (Skin Infections) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: MRSA Drugs (Skin Infections) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: MRSA Drugs (Bone and Joint Infections) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: MRSA Drugs (Bone and Joint Infections) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: MRSA Drugs (Bacteremia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: MRSA Drugs (Bacteremia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: MRSA Drugs (Animal Infections) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: MRSA Drugs (Animal Infections) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: MRSA Drugs (Oral Administration) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: MRSA Drugs (Oral Administration) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: MRSA Drugs (Parenteral Administration) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: MRSA Drugs (Parenteral Administration) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: MRSA Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: MRSA Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Global: MRSA Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Global: MRSA Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Global: MRSA Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Global: MRSA Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: North America: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: North America: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: United States: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: United States: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Canada: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Canada: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Asia-Pacific: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Asia-Pacific: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: China: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: China: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Japan: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Japan: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: India: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: India: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: South Korea: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: South Korea: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Australia: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Australia: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Indonesia: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Indonesia: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Europe: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Europe: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Germany: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Germany: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: France: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: France: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: United Kingdom: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: United Kingdom: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Italy: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Italy: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Spain: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Spain: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Russia: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Russia: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Others: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Others: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Latin America: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Latin America: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Brazil: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Brazil: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Mexico: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Mexico: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Others: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 89: Others: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Middle East and Africa: MRSA Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 91: Middle East and Africa: MRSA Drugs Market: Breakup by Country (in %), 2022
Figure 92: Middle East and Africa: MRSA Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 93: Global: MRSA Drugs Industry: Drivers, Restraints, and Opportunities
Figure 94: Global: MRSA Drugs Industry: Value Chain Analysis
Figure 95: Global: MRSA Drugs Industry: Porter's Five Forces Analysis